Casey Woodring
Stock Analyst at JP Morgan
(1.11)
# 3,433
Out of 5,093 analysts
52
Total ratings
34.48%
Success rate
-10.05%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Maintains: Overweight | $150 → $145 | $100.00 | +45.00% | 2 | Dec 10, 2025 | |
| NTRA Natera | Maintains: Overweight | $240 → $250 | $236.24 | +5.82% | 2 | Nov 25, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $165 → $180 | $141.94 | +26.81% | 2 | Nov 25, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $26 → $22 | $28.14 | -21.82% | 5 | Nov 7, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $13 → $15 | $18.18 | -17.49% | 1 | Nov 7, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $160 → $165 | $188.72 | -12.57% | 9 | Nov 6, 2025 | |
| SHC Sotera Health Company | Maintains: Neutral | $14 → $16 | $16.91 | -5.38% | 3 | Nov 5, 2025 | |
| ILMN Illumina | Maintains: Neutral | $100 → $105 | $133.67 | -21.45% | 1 | Oct 31, 2025 | |
| AVTR Avantor | Downgrades: Neutral | $14 → $12 | $11.15 | +7.62% | 1 | Oct 30, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $177 → $255 | $221.60 | +15.07% | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $78 | $75.02 | +3.97% | 6 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $325 | $392.38 | -17.17% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $600 → $650 | $568.01 | +14.43% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1,200 → $1,285 | $1,393.47 | -7.78% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $104.25 | -32.85% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $265 → $150 | $183.98 | -18.47% | 6 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $56 | $45.83 | +21.36% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.48 | +141.94% | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $23 | $21.14 | +8.80% | 2 | Oct 31, 2023 |
BillionToOne
Dec 10, 2025
Maintains: Overweight
Price Target: $150 → $145
Current: $100.00
Upside: +45.00%
Natera
Nov 25, 2025
Maintains: Overweight
Price Target: $240 → $250
Current: $236.24
Upside: +5.82%
Agilent Technologies
Nov 25, 2025
Maintains: Overweight
Price Target: $165 → $180
Current: $141.94
Upside: +26.81%
QuidelOrtho
Nov 7, 2025
Maintains: Underweight
Price Target: $26 → $22
Current: $28.14
Upside: -21.82%
10x Genomics
Nov 7, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $18.18
Upside: -17.49%
Charles River Laboratories International
Nov 6, 2025
Maintains: Neutral
Price Target: $160 → $165
Current: $188.72
Upside: -12.57%
Sotera Health Company
Nov 5, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $16.91
Upside: -5.38%
Illumina
Oct 31, 2025
Maintains: Neutral
Price Target: $100 → $105
Current: $133.67
Upside: -21.45%
Avantor
Oct 30, 2025
Downgrades: Neutral
Price Target: $14 → $12
Current: $11.15
Upside: +7.62%
IQVIA Holdings
Oct 29, 2025
Maintains: Overweight
Price Target: $177 → $255
Current: $221.60
Upside: +15.07%
Oct 22, 2025
Downgrades: Neutral
Price Target: $78
Current: $75.02
Upside: +3.97%
Oct 9, 2025
Maintains: Neutral
Price Target: $300 → $325
Current: $392.38
Upside: -17.17%
Oct 9, 2025
Maintains: Overweight
Price Target: $600 → $650
Current: $568.01
Upside: +14.43%
Oct 9, 2025
Maintains: Neutral
Price Target: $1,200 → $1,285
Current: $1,393.47
Upside: -7.78%
Sep 25, 2025
Maintains: Overweight
Price Target: $60 → $70
Current: $104.25
Upside: -32.85%
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $183.98
Upside: -18.47%
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $45.83
Upside: +21.36%
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.48
Upside: +141.94%
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $21.14
Upside: +8.80%